Has Jyothsna Bandaru, MD received payments from drug or device companies?

Yes. Drug and device makers reported $805 in general payments to Jyothsna Bandaru, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jyothsna Bandaru, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jyothsna Bandaru, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jyothsna Bandaru, MD

Internal Medicine · Fort Myers, FLNPI 1013362086

Payments from drug & device makers

$805in general payments, 2019–2025

Across 8 payments — averaging $100.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$250
Boehringer Ingelheim$120
Dexcom, Inc.$112
Abbott$109
Medtronic$104
Lilly USA, LLC$85
plus $25 from 1 others

What the payments were for

Food & beverage$805100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	2	$250
Boehringer Ingelheim	1	$120
Dexcom, Inc.	1	$112
Abbott	1	$109
Medtronic	1	$104
Lilly USA, LLC	1	$85
ERBE USA Inc	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$805 in reported general payments places this provider in the 65th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$72,721

Medicare patients

120

Services billed

649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	24	$422
Hydralazine Hcl	13	$144
Lactulose	11	$65
Prednisone	11	$41
Carvedilol	14	$32
Furosemide	11	$30

Paid to pharmacies, not to this prescriber.

Other internal medicine in Fort Myers

Yaneicy Gonzalez RojasCoral Gables$93.5M
Juan Carlos RondonHollywood$66.8M
Jaynier MoyaPembroke Pines$45.4M
Mark KutnerMiami$35.7M
Gilberto JimenezHialeah$35.6M
Mira BaronWest Palm Beach$29.6M
William SanchezHialeah$28.9M
Nelia Sanchez-CrespoHollywood$28.8M
Kwabena AyesuOrlando$27.6M
Michael DeverWindermere$24M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →